| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 12 | |
| #2 | EPO (European Patent Office) | 10 | |
| #3 | Canada | 4 | |
| #4 | Mexico | 4 | |
| #5 | Australia | 3 | |
| #6 | China | 3 | |
| #7 | Brazil | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | Israel | 1 | |
| #10 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lichty Brian | 23 |
| #2 | Bell John | 18 |
| #3 | Bell John Cameron | 11 |
| #4 | Stojdl David F | 8 |
| #5 | Stephenson Kyle | 6 |
| #6 | Atherton Matthew | 6 |
| #7 | Brian Lichty | 5 |
| #8 | Diallo Jean-Simon | 5 |
| #9 | Huh Michael | 4 |
| #10 | Evgin Laura | 4 |
| Publication | Filing date | Title |
|---|---|---|
| CA3091969A1 | Oncolytic viruses as adjuvants | |
| EP3497208A1 | Oncolytic rhabdovirus expressing il12 | |
| CA3024653A1 | Pseudotyped oncolytic rhabdoviruses and their use in combination therapy | |
| KR20190038480A | Prime: boost combination therapy | |
| CN109069561A | Oncolytic virus and checkpoint inhibitor combination treatment | |
| EP2958994A1 | Vaccine composition | |
| CN108126204A | Method of vaccination comprising histon deacetylase (HDAC) inhibitor |